Prostacyclin-analog therapy in sickle cell pulmonary hypertension

• Nargues A. Weir,
• Rehan Saiyed,
• Shoaib Alam,
• Anna Conrey,
• Himanshu D. Desai,
• M. Patricia George,
• Jennifer H. Keeley,
• Elizabeth S. Klings,
• Alem Mehari,
• James G. Taylor,
• Caterina P. Minniti,
• Gregory J. Kato

Affiliations

Nargues A. Weir

Cardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD

Rehan Saiyed

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Shoaib Alam

Cardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD

Anna Conrey

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Himanshu D. Desai

Pulmonary Medicine, Eastern Virginia Medical School, Norfolk, VA

M. Patricia George

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, PA

Jennifer H. Keeley

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, PA

Elizabeth S. Klings

The Pulmonary Center, Boston University School of Medicine, MA

Alem Mehari

Division of Pulmonary Medicine, Department of Medicine, Howard University, Washington DC, MD

James G. Taylor

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Caterina P. Minniti

Division of Hematology, Albert Einstein College of Medicine, Bronx, New York, NY

Gregory J. Kato

Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, PA, USA